GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 134 filers reported holding GOSSAMER BIO INC in Q2 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $74 | -100.0% | 33,911 | +17.9% | 0.01% | -79.4% |
Q3 2022 | $345,000 | +63.5% | 28,773 | +18.1% | 0.03% | +36.0% |
Q1 2022 | $211,000 | +27.1% | 24,354 | +35.5% | 0.02% | +31.6% |
Q1 2021 | $166,000 | -15.3% | 17,973 | -11.2% | 0.02% | -40.6% |
Q4 2020 | $196,000 | – | 20,236 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 3,320,608 | $41,740,000 | 4.68% |
Octagon Capital Advisors LP | 1,513,138 | $19,020,000 | 4.68% |
Ally Bridge Group (NY) LLC | 1,175,000 | $14,770,000 | 4.34% |
Parkman Healthcare Partners LLC | 786,870 | $9,891,000 | 2.50% |
Palo Alto Investors LP | 1,772,950 | $22,286,000 | 1.34% |
HHLR ADVISORS, LTD. | 7,420,974 | $93,282,000 | 1.22% |
Ikarian Capital, LLC | 1,351,933 | $16,995,000 | 1.20% |
Boxer Capital, LLC | 2,462,358 | $30,952,000 | 1.08% |
ACUTA CAPITAL PARTNERS, LLC | 215,000 | $2,703,000 | 0.95% |
EMERALD ADVISERS, LLC | 1,516,003 | $19,056,000 | 0.69% |